Monday, August 26, 2019

Ray of hope for terminally-ill patients as new norms may allow use of experimental drugs

Ray of hope for terminally-ill patients as new norms may allow use of experimental drugs Currently, patients can use only those drugs which are approved by the drug regulator after it has passed clinical trials and found safe and efficacious, a process that takes several years. However, a new policy in the works will allow them to access pre-approval drugs in cases of serious and life-threatening diseases on compassionate grounds, without clearing clinical trials.

from Moneycontrol Business News https://ift.tt/2KVOaWm

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...